Astellas is prohibited from buying shares of Ocata as that would be the same as insider trading. This deal is not going to work as is, insiders only control 1.7 % of the shares. Astellas has two options, either raise the price or walk away. I guess they might have a third option of Ocata management explaining why $8.50 makes sense but they are not able or willing to do. Its criminal that no other company is coming forward, or someone like Steve Wynn. But really we would be better for this deal to go away.
Institutions will own over 30% of shares when NASDAQ next reports next month. It's obvious that some retail has been scared into selling. It's the way it works but hopefully retail will still own a majority of shares. Seems only fair that the future share appreciation go to retail investors that have been here for a long time. Holding shares of this company has certainly been educational and maybe miraculously will in the next few years be life changing. Anything under $8.00 is a discount to what the shares are worth presently.
To reach $3000. they would need to be another Apple and dominate their sector, not sure that's possible but if they have normal success we could see $100 to $500 in next seven to ten years. Pps could see $8.00 to $12.00 in next nine months, which would be great and the company will finally put their finance problems behind them.
Guidance by management is second quarter next year will see first results reported for beginning of phase II. We already know the therapy is safe and it works, we are waiting to see to what extent it works. The whole industry is keeping fingers crossed because if results are good it will help give an air of legitimacy to the technology. Regenerative Medicine could save the country trillions in future un-funded healthcare liabilities. Which means this little company may get credit for saving us all from bankruptcy. It's vital that this works.
We now know this company is making progress and their credibility is vastly been improved. This now looks like a company that just needs time meaning investors who have confidence in the science will need a lot of patience. The potential rewards are too large to visualize at this stage. Life says things can go wrong but what we now know suggests we have a legitimate chance for making some serious money in the next few months and years.